Decanini A, Karunadharma P R, Nordgaard C L, Feng X, Olsen T W, Ferrington D A
Department of Ophthalmology, University of Minnesota, 380 Lions Research Bldg., 2001 6th St SE, Minneapolis, MN 55455, USA.
Diabetologia. 2008 Jun;51(6):1051-61. doi: 10.1007/s00125-008-0991-2. Epub 2008 Apr 15.
AIMS/HYPOTHESIS: Diabetic retinopathy is the most common complication of diabetes and a leading cause of blindness among working-age adults. Anatomical and functional changes occur in the retina and retinal pigment epithelium (RPE) prior to clinical symptoms of the disease. However, the molecular mechanisms responsible for these early changes, particularly in the RPE, remain unclear. To begin defining the molecular changes associated with pre-retinopathic diabetes, we conducted a comparative proteomics study of human donor RPE.
The RPE was dissected from diabetic human donor eyes with no clinically apparent diabetic retinopathy (n=6) and from eyes of age-matched control donors (n=17). Soluble proteins were separated based upon their mass and charge using two-dimensional (2-D) gel electrophoresis. Protein spots were visualised with a fluorescent dye and spot densities were compared between diabetic and control gels. Proteins from spots with significant disease-related changes in density were identified using mass spectrometry.
Analysis of 325 spots on 2-D gels identified 31 spots that were either up- or downregulated relative to those from age-matched control donors. The protein identity of 18 spots was determined by mass spectrometry. A majority of altered proteins belonged to two major functional groups, metabolism and chaperones, while other affected categories included protein degradation, synthesis and transport, oxidoreductases, cytoskeletal structure and retinoid metabolism.
CONCLUSIONS/INTERPRETATION: Changes identified in the RPE proteome of pre-retinopathic diabetic donor eyes compared with age-matched controls suggest specific cellular alterations that may contribute to diabetic retinopathy. Defining the pre-retinopathic changes affecting the RPE could provide important insight into the molecular events that lead to this disease.
目的/假设:糖尿病视网膜病变是糖尿病最常见的并发症,也是劳动年龄成年人失明的主要原因。在该疾病出现临床症状之前,视网膜和视网膜色素上皮(RPE)就会发生解剖学和功能上的变化。然而,导致这些早期变化的分子机制,尤其是RPE中的机制,仍不清楚。为了开始确定与视网膜病变前期糖尿病相关的分子变化,我们对人类供体RPE进行了一项比较蛋白质组学研究。
从无临床明显糖尿病视网膜病变的糖尿病人类供体眼睛(n = 6)和年龄匹配的对照供体眼睛(n = 17)中分离出RPE。使用二维(2-D)凝胶电泳根据蛋白质的质量和电荷分离可溶性蛋白质。用荧光染料使蛋白质斑点可视化,并比较糖尿病凝胶和对照凝胶之间的斑点密度。使用质谱法鉴定密度有显著疾病相关变化的斑点中的蛋白质。
对2-D凝胶上的325个斑点进行分析,确定了31个相对于年龄匹配的对照供体上调或下调的斑点。通过质谱法确定了18个斑点的蛋白质身份。大多数改变的蛋白质属于两个主要功能组,即代谢和伴侣蛋白,而其他受影响的类别包括蛋白质降解、合成和运输、氧化还原酶、细胞骨架结构和类视黄醇代谢。
结论/解读:与年龄匹配的对照相比,在视网膜病变前期糖尿病供体眼睛的RPE蛋白质组中发现的变化表明特定的细胞改变可能导致糖尿病视网膜病变。确定影响RPE的视网膜病变前期变化可以为导致该疾病的分子事件提供重要见解。